Neurotech, Neuromodulation, Alzheimers.
Disease, was granted an FDA breakthrough designation in 2020. “The device, consisting of a cap and arm control box, is worn twice a day for an hour at a time, and is designed to allow patients to move around their home as usual. MemorEM features the company’s proprietary transcranial